DNA X, Inc. - 8-K Filing

DNA X, Inc. approves substitute cash grant for acting CEO Mike Mulica due to lack of available equity under 2019 Equity Incentive Plan.

SEC EDGAR ·

Tickers: $SONM

Read the full article at SEC EDGAR

More Regulatory news